The effect of inducers of mixed-function oxidases on hepatic microsome-mediated aflatoxin B1 transformation in C3H/10T1/2 cells.
The effect of inducers of mixed-function oxidases on hepatic microsome-mediated aflatoxin B1 transformation in C3H/10T1/2 cells.
复制标题
混合功能氧化酶诱导剂对 C3H/10T1/2 细胞中肝微粒体介导的黄曲霉毒素 B1 转化的影响。
DOI:
10.1016/0041-008x(89)90230-5
复制
发表时间:
1989
影响因子:
3.8
通讯作者:
Gurtoo,HL
中科院分区:
文献类型:
--
作者:
Faletto,MB;Gurtoo,HL
The potent hepatotoxin and hepatocarcinogen aflatoxin B1(AFB1) is metabolized by different forms of cytochrome P450 associated with the hepatic mixed-function oxidase system. C3H 10T 1 2 (10 T 1 2 ) cells, which have limited inherent capacity to metabolize AFB1, were treated with AFB1in the presence of hepatic microsomes isolated from chemically treated rats to investigate the effects of the induction of specific cytochromes P450 on AFB1-mediated toxicity and transformation. Relative to uninduced microsomes, phenobarbital (PB) treatment induced AFB1-DNA binding (essentially representing the formation of AFB1-8,9-oxide bound to DNA) 3.2-fold, while pretreatment with Aroclor 1254, 3-methylcholanthrene (3-MC), or 5,6-benzoflavone (β-NF) preferentially induced aflatoxin M1(AFM1) formation from 2- to 5-fold. 10 T 1 2 cells were exposed to a multiple treatment regimen with 4 μm AFB1and hepatic microsomes from uninduced, PB-, Aroclor 1254-, 3-MC-, or β-NF-treated rats; respective cumulative toxicities of approximately 90, 95, 70, 60, and 40% control (no microsomes) values resulted. An enhanced AFB1transformation response correlated with the increasing toxicities observed for the different treatments, with uninduced or PB-induced microsomes yielding approximately four foci/dish, while treatments with Aroclor 1254-, 3-MC-, or β-NF-induced microsomes resulted in only one to two foci/dish. These results demonstrate that AFB1is a complete carcinogen in the 10 T 1 2 system when repetitive incubations are used in conjunction with an appropriate hepatic microsomal activation system. These data also correlate the induction of AFB1-4-hydroxylase with a decrease in AFB1-mediated toxicity and transformation of 10 T 1 2 cells, and support the hypothesis that the Phase I metabolic conversion of AFB1to AFM1in the liver represents an effective detoxication pathway per se.